Obesity influences the risk of HT, i.e., through activation of the renin–angiotensin–aldosterone (RAS) system, activation of mineralocorticoid receptors, and activation of the sympathetic nervous system (SNS) (24). Here, NR3C2 is linked to hematocrit.